Publication: 2636

Publication: 2636

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Pharmacol vol 60 (4) 444-452

Year:: 2020
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 9

Parents:: None
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:: Breast

Pharmas:
Grants:: U10CA180821, U10CA180882, CA025224, U10CA032291, U10CA041287, U10CA077651, U10CA108068, U10CA138561, U10CA180790, U10CA180791, 5UG1CA189830, U10CA180836, U10CA180867, K12CA139160

Corr. Author:
Authors:: Manish R. Sharma Shailly Mehrotra Elizabeth Gray Kehua Wu William T. Barry Clifford Hudis Eric P. Winer Alan P. Lyss Deborah L. Toppmeyer Alvaro Moreno-Aspitia Thomas E. Lad Mario Velasco Beth Overmoyer Hope S. Rugo Mark J. Ratain Jogarao V. Gobburu

Networks:: CA824, CRCWM, HEARTLAND, IL018, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY016, MD015, STROGER

Study: CALGB-40502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: chemotherapy, breast cancer, modeling and simulation, neuropathy, personalized